Breaking News

Lonza Completes First GMP Batch at Mammalian Mfg. Facility

New 2,000L asset will support small- to mid-volume products, such as therapies targeting rare diseases.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lonza, a global development and manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, completed the first GMP product batch supported from the recently completed next-generation mammalian manufacturing facility in Portsmouth, NH.   The first GMP batch release marks a milestone, allowing the facility to help meet the increasing market demand for small- to mid-scale volumes of mammalian-derived biologics and support the implementation of high-titer and high-throughput ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters